Altamira Therapeutics Ltd. Interest Received Classified As Investing Activities
Altamira Therapeutics Ltd. (CYTOF) reported Interest Received Classified As Investing Activities of $3.33 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:InterestReceivedClassifiedAsInvestingActivities · last filed 2025-08-29
CHF
| Period end | Interest Received Classified As Investing Activities 6 month | Interest Received Classified As Investing Activities 12 month |
|---|---|---|
| 2023-12-31 | 505.00 CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 240.00 CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 969.00 CHF 20-F/A · filed 2024-04-22 | |
| 2020-12-31 | 258.00 CHF 20-F · filed 2023-05-16 | |
| 2019-12-31 | 17.88K CHF 20-F · filed 2022-04-12 | |
| 2018-12-31 | 0.00 CHF 20-F · filed 2019-03-14 | |
| 2017-12-31 | 53.57K CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | 67.55K CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 36.56K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Interest Received Classified As Investing Activities 6 month | Interest Received Classified As Investing Activities 12 month |
|---|---|---|
| 2024-12-31 | $3.33K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $513.00 6-K · filed 2025-08-29 | |
| 2023-12-31 | $562.00 20-F · filed 2025-04-30 | |
| 2023-06-30 | $263.00 6-K · filed 2024-09-24 | |
| 2022-12-31 | $1.01K 20-F · filed 2025-04-30 |